Atea Pharmaceuticals, Inc. - AVIR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | See Remarks | M | A | 60,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 13, 2026 | See Remarks | M | A | 60,000.0 | 1.24 | 74,400.0 | 823,576.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | A | A | 173,500.0 | 0.0 | 0.0 | 173,500.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | M | D | 9,750.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | M | D | 41,533.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | F | D | 16,073.0 | 4.24 | 68,149.52 | 96,086.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | M | A | 51,283.0 | — | — | 112,159.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | A | A | 119,520.0 | 0.0 | 0.0 | 119,520.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | M | D | 8,750.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | M | D | 33,333.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | F | D | 11,570.0 | 4.24 | 49,056.8 | 82,594.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | M | A | 42,083.0 | — | — | 94,164.0 | View | |
| Feb 03, 2026 | Chief Development Officer | A | A | 177,000.0 | 0.0 | 0.0 | 177,000.0 | View | |
| Feb 03, 2026 | Chief Development Officer | M | D | 11,250.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Development Officer | M | D | 46,800.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Development Officer | F | D | 14,136.0 | 4.24 | 59,936.64 | 127,665.0 | View | |
| Feb 03, 2026 | Chief Development Officer | M | A | 58,050.0 | — | — | 141,801.0 | View | |
| Feb 03, 2026 | See Remarks | A | A | 180,000.0 | 0.0 | 0.0 | 180,000.0 | View | |
| Feb 03, 2026 | See Remarks | M | D | 10,500.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | See Remarks | M | D | 44,366.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | See Remarks | F | D | 16,104.0 | 4.24 | 68,280.96 | 763,576.0 | View | |
| Feb 03, 2026 | See Remarks | M | A | 54,866.0 | — | — | 779,680.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | M | D | 300,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | M | D | 99,517.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | M | D | 173,466.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | M | A | 300,000.0 | 1.24 | 372,000.0 | 767,830.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | F | D | 106,093.0 | 4.24 | 449,834.32 | 467,830.0 | View | |
| Feb 03, 2026 | President, CEO, and Chairman | M | A | 272,983.0 | — | — | 573,923.0 | View | |
| Feb 03, 2026 | EVP, Chief Accounting Officer | A | A | 108,000.0 | 0.0 | 0.0 | 108,000.0 | View | |
| Feb 03, 2026 | EVP, Chief Accounting Officer | M | D | 8,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | EVP, Chief Accounting Officer | M | D | 33,333.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | EVP, Chief Accounting Officer | F | D | 12,132.0 | 4.24 | 51,439.68 | 79,329.0 | View | |
| Feb 03, 2026 | EVP, Chief Accounting Officer | M | A | 41,333.0 | — | — | 91,461.0 | View |